drugset / Trial / NCT00529126

Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy

NCT00529126

Phase 2 Completed 100 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupTriple-blindTreatment

Summary

Phase 2 study to evaluate three dose levels of SKY0402 compared with 75 mg of bupivacaine HCl.

Timeline

Start
2007-09
Primary completion
2007-12
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 75 mg Other
Subject SKY0402 Unknown Other

Indications

No indication recorded.